SNMMI Theranostics Tumor Board - Theranostics in Oncology: From Precision Targeting to Clinical Practice

At a glance

Dates

Thursday, December 10, 2026Source schedule: 12/10/2026 12:00 PM - 1:00 PM Eastern Standard Time

Where

Online

Format

Online

Credits

CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.

Registration and access

View registration and access notes

SNMMI Theranostics Tumor Board - Theranostics in Oncology: From Precision Targeting to Clinical Practice Thursday, December 10, 2026 | 12:00 pm ET Sponsored by the SNMMI Theranostics Leadership and Operations Group (TLOG) Organizer/Moderator: Lisa Bodei, MD, PhD Speaker(s): Jonathan Kuten, MD Michael J. Morris, MD Anis Hamid, MD Nitya Raj, MD Rohit Thummalapalli, MD Lauren Britt, NP Memorial Sloan Kettering Cancer Center Course Objectives Upon completion of this session, participants will be able to: 1. Describe the principles and clinical applications of FDA-approved theranostic radiopharmaceuticals in prostate cancer and neuroendocrine tumors. 2. Identify appropriate candidates for theranostic treatments based on approved indications, clinical criteria, and molecular imaging findings. 3. Evaluate the evidence supporting the efficacy and safety of theranostic therapies and their integration into multidisciplinary cancer management. CE Information: CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status. Sign in or create an account to register. Registration ends 12/10/2026 1:00 PM EST

Cost

Price information is not available here. Check the official page.

Registration deadline

Thursday, December 10, 2026 at 13:00 (America/New_York)in 40 daysCheck the official page for the latest deadline.

Organizer

Society of Nuclear Medicine and Molecular Imaging